The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.50
Bid: 40.00
Ask: 41.00
Change: -1.00 (-2.41%)
Spread: 1.00 (2.50%)
Open: 41.50
High: 41.50
Low: 40.50
Prev. Close: 41.50
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investor evening

20 Dec 2016 07:00

RNS Number : 2870S
Venture Life Group PLC
20 December 2016
 

20 December 2016

Venture Life Group plc

("Venture Life", the "Company" or the "Group")

 

Investor evening

 

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that it will be hosting a presentation for investors on the afternoon of Thursday 26 January 2017.

 

Jerry Randall, CEO will provide an overview of the Company and where it is currently positioned. The afternoon will also feature presentations by:

 

· Mr Vincent Poujardieu, Vice President of Rasio Group plc and General Manager of the Benecol Division. Vincent will be speaking about Benecol and the benefits the brand offers as a functional food and a food supplement.

· Mr Gianluca Braguti, founder of Biokosmes and Development and Manufacturing Director at Venture Life. Gianluca will be speaking about the new products developed at Biokosmes, including new Benecol products, to be launched in 2017 by Venture Life.

· Dr Mervyn Druian, Aesthetic Dentist. Mervyn originally brought the UltraDEX product to the UK more than 20 years ago. He has successfully used UltraDEX long term in his clinic in Primrose Hill, and will be speaking about the benefits of UltraDEX for his patients and the advantages it offers over the competition.

· Mr Tim Scott, UK Sales Director, Venture Life. Tim has recently joined Venture Life and has extensive experience in the UK retail pharmacy space. Tim will talk about the UK market trends in both the pharmacy and grocery sector and also about the commercial opportunity for UltraDEX in the UK.

 

The presentation will be held at the offices of Panmure Gordon, One New Change, London EC4M 9AF. The event will begin at 3pm, and after brief presentations, drinks and canapes will be served to allow guests to talk further with the speakers.

 

Space is limited so please register your interest, please contact venturelife@walbrookpr.com or call 020 7933 8780.

 

No new material or trading information will be provided.

 

For further information please contact:

 

Venture Life Group PLC

+44 (0) 1344 742870

Jerry Randall, Chief Executive Officer

 

 

 

Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 7886 2500

Freddy Crossley/Peter Steel/Duncan Monteith (Corporate Finance)

 

Tom Salvesen (Corporate Broking)

 

 

Turner Pope Investments (TPI) Ltd (Joint Broker)

+44 (0) 20 3621 4120

James Pope/Ben Turner

 

 

Walbrook PR

venturelife@walbrookpr.com or +44 (0) 20 7933 8780

Paul McManus/Anna Dunphy

+44 (0) 7980 541 893 / +44 (0) 7876 741 001

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFERFSLALIR
Date   Source Headline
1st Mar 201612:07 pmRNSResult of General Meeting and Issue of Equity
18th Feb 201610:20 amRNSDirectorate Change
12th Feb 20165:38 pmRNSCircular Publication & Notice of General Meeting
12th Feb 201612:11 pmRNSResults of Placing to Partially Fund Acquisition
12th Feb 20167:00 amRNSProposed Placing and issue of Convertible Bonds
13th Jan 20167:00 amRNSProduct Launch
23rd Dec 20157:38 amRNSTrading Update
29th Sep 20157:00 amRNSInterim Results
9th Sep 20157:00 amRNSNotice of Results
9th Jul 20157:00 amRNSPre-Close Trading Statement
10th Jun 201511:41 amRNSAGM Statement
9th Jun 20157:00 amRNSStrategic Development and Commercial Alliance
22nd May 20157:00 amRNSPDMR Shareholding
15th Apr 20157:00 amRNS2014 Annual Report and Dividend Timetable
25th Mar 20157:00 amRNSFinal Results
16th Mar 20157:00 amRNSSale of trademarks: manufacturing agreement signed
26th Jan 20157:00 amRNS30-year exclusive distribution deal signed
9th Dec 20147:00 amRNSBenecol Supplement Capsule Sale Malta
4th Dec 201411:54 amRNSHolding(s) in Company
28th Nov 20147:00 amRNSShare Placing
19th Nov 20147:00 amRNSAppointment of Nominated Adviser and Broker
10th Oct 20147:00 amRNSDirector's Dealings
8th Oct 20147:00 amRNSDirector Dealings
6th Oct 20147:00 amRNSDirectors' Dealings
1st Oct 20147:00 amRNSInvestor Forum
29th Sep 20147:00 amRNSInterim Results
23rd Sep 20147:00 amRNSNew distribution agreements
5th Sep 20147:00 amRNSNotice of Interim Results
6th Aug 20147:00 amRNSNew Product Development and Board Change
7th Jul 20147:00 amRNSNew distribution agreement signed
30th Jun 201412:09 pmRNSAGM Statement
30th Jun 20147:00 amRNSTotal Voting Rights
25th Jun 20147:00 amRNSNew distribution agreements signed
17th Jun 20147:00 amRNSAppointment of Non-Executive Director
13th Jun 20149:44 amRNSHolding(s) in Company
5th Jun 20147:01 amRNSIssue of new shares
5th Jun 20147:00 amRNSFinal Results
23rd Apr 20147:00 amRNSNew Distribution Agreement
28th Mar 20148:00 amRNSAdmission to AIM and Acquisition of Biokosmes Srl

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.